Advertisement
News
Advertisement

Metamark raises $13M in Series B round

Fri, 11/16/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Two weeks after announcing the resignation of its CEO, Metamark Genetics Inc. in Cambridge has filed for the receipt of $9 million out of a $13 million Series B round of financing which it plans to use for final clinical validation of two prostate cancer prognostic tests.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading